A majority in U.S. see net benefits of  | allowing access to experimental drugs  | % ofU.S. adults who say  | in allowing more people  | access to experimental drugs for treatment of a serious  | illness or disease BEFORE clinical trials have shown the  | drugs to be safe and effective  | The benefits  | The risks  | outweigh  | outweigh  | the benefits  | the risks  | U.S adults  | 40  | 59  | White  | 36  | 63  | Black  | 41  | 57  | Hispanic  | 46  | 53  | Boomer & older  | 33  | 64  | Gen X  | 38  | 61  | Millennial younger  | 47  | 51  | Rep/lean Rep  | 29  | 69  | Dem/lean Dem  | 48  | 50  | Note: Respondents who did not give an answer are not shown.  | Whites and blacks include those who report being only Jone race and  | are non-Hispanic. Hispanics are of any race.  | Source: Survey conducted April 29-May 5, 2020.  | "Trust in Medical Scientists Has 29-May Grown in U.S., but Mainly Among  | Democrats  | PEW RESEARCH CENTER 